KEGG   PATHWAY: ko05012Help
Entry
ko05012                     Pathway                                

Name
Parkinson's disease
Description
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. These pathogenic mutations are associated with disease through pathogenic pathways that may commonly lead proteasome dysfunction, mitochondrial impairment, and oxidative stress. Point mutations in alpha-synuclein lead to excessive intracellular accumulation and protofibril formation. Decrease in the amount of soluble alpha-synuclein tends to increase free cytoplasmic dopamine and the formation of reactive oxygen species (ROS). Modification of parkin and UCHL1 are associated with the ubiquitin-proteasome system pathway and may increase proteotoxic stress. Mutations in parkin, DJ1, and PINK1 may alter mitochondiral activity, potentially impairing proteasomal function. Environmental toxins such as N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and rotenone can cause mitochondrial dysfunction and oxidative stress.
Class
Human Diseases; Neurodegenerative diseases
BRITE hierarchy
Pathway map
Parkinson's disease
ko05012

All organismsOrtholog table
Disease
H00057  
Parkinson's disease (PD)
H00473  
Mitochondrial respiratory chain deficiencies (MRCD)
H00831  
Primary dystonia
Orthology
K03178  
ubiquitin-activating enzyme E1 [EC:6.3.2.19]
K10698  
ubiquitin-activating enzyme E1-like [EC:6.3.2.19]
K04551  
ubiquitin B
K04552  
ubiquitin-conjugating enzyme E2 L3 [EC:6.3.2.19]
K04553  
ubiquitin-conjugating enzyme E2 L6 [EC:6.3.2.19]
K04554  
ubiquitin-conjugating enzyme E2 J2 [EC:6.3.2.19]
K10578  
ubiquitin-conjugating enzyme E2 J1 [EC:6.3.2.19]
K04555  
ubiquitin-conjugating enzyme E2 G2 [EC:6.3.2.19]
K10575  
ubiquitin-conjugating enzyme E2 G1 [EC:6.3.2.19]
K04556  
parkin [EC:6.3.2.19]
K04528  
synuclein, alpha (non A4 component of amyloid precursor)
K04243  
G protein-coupled receptor 37 (endothelin receptor type B-like)
K04557  
septin 5
K04558  
synuclein, alpha interacting protein (synphilin)
K05611  
ubiquitin carboxyl-terminal hydrolase L1 [EC:3.4.19.12]
K00501  
tyrosine 3-monooxygenase [EC:1.14.16.2]
K05036  
solute carrier family 6 (neurotransmitter transporter, dopamine) member 3
K08155  
MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K03878  
NADH-ubiquinone oxidoreductase chain 1 [EC:1.6.5.3]
K03879  
NADH-ubiquinone oxidoreductase chain 2 [EC:1.6.5.3]
K03880  
NADH-ubiquinone oxidoreductase chain 3 [EC:1.6.5.3]
K03881  
NADH-ubiquinone oxidoreductase chain 4 [EC:1.6.5.3]
K03882  
NADH-ubiquinone oxidoreductase chain 4L [EC:1.6.5.3]
K03883  
NADH-ubiquinone oxidoreductase chain 5 [EC:1.6.5.3]
K03884  
NADH-ubiquinone oxidoreductase chain 6 [EC:1.6.5.3]
K03942  
NADH dehydrogenase (ubiquinone) flavoprotein 1 [EC:1.6.99.3 1.6.5.3]
K03943  
NADH dehydrogenase (ubiquinone) flavoprotein 2 [EC:1.6.99.3 1.6.5.3]
K03944  
NADH dehydrogenase (ubiquinone) flavoprotein 3 [EC:1.6.99.3 1.6.5.3]
K03945  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 1 [EC:1.6.99.3 1.6.5.3]
K03946  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 2 [EC:1.6.99.3 1.6.5.3]
K03947  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 3 [EC:1.6.99.3 1.6.5.3]
K03948  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4 [EC:1.6.99.3 1.6.5.3]
K03949  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 [EC:1.6.99.3 1.6.5.3]
K03950  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 6 [EC:1.6.99.3 1.6.5.3]
K03951  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 7 [EC:1.6.99.3 1.6.5.3]
K03952  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 8 [EC:1.6.99.3 1.6.5.3]
K03953  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 9 [EC:1.6.99.3 1.6.5.3]
K03954  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 [EC:1.6.99.3 1.6.5.3]
K03955  
NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex 1 [EC:1.6.99.3 1.6.5.3]
K03956  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 [EC:1.6.5.3]
K11352  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 12 [EC:1.6.99.3 1.6.5.3]
K11353  
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 13 [EC:1.6.99.3 1.6.5.3]
K03957  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 1 [EC:1.6.99.3 1.6.5.3]
K03958  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 2 [EC:1.6.99.3 1.6.5.3]
K03959  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 [EC:1.6.99.3 1.6.5.3]
K03960  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 [EC:1.6.99.3 1.6.5.3]
K03961  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 5 [EC:1.6.99.3 1.6.5.3]
K03962  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 6 [EC:1.6.99.3 1.6.5.3]
K03963  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 7 [EC:1.6.99.3 1.6.5.3]
K03964  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 [EC:1.6.99.3 1.6.5.3]
K03965  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 [EC:1.6.99.3 1.6.5.3]
K03966  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 10 [EC:1.6.99.3 1.6.5.3]
K11351  
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 11 [EC:1.6.99.3 1.6.5.3]
K03934  
NADH dehydrogenase (ubiquinone) Fe-S protein 1 [EC:1.6.99.3 1.6.5.3]
K03935  
NADH dehydrogenase (ubiquinone) Fe-S protein 2 [EC:1.6.99.3 1.6.5.3]
K03936  
NADH dehydrogenase (ubiquinone) Fe-S protein 3 [EC:1.6.99.3 1.6.5.3]
K03937  
NADH dehydrogenase (ubiquinone) Fe-S protein 4 [EC:1.6.99.3 1.6.5.3]
K03938  
NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.99.3 1.6.5.3]
K03939  
NADH dehydrogenase (ubiquinone) Fe-S protein 6 [EC:1.6.99.3 1.6.5.3]
K03940  
NADH dehydrogenase (ubiquinone) Fe-S protein 7 [EC:1.6.99.3 1.6.5.3]
K03941  
NADH dehydrogenase (ubiquinone) Fe-S protein 8 [EC:1.6.99.3 1.6.5.3]
K03967  
NADH dehydrogenase (ubiquinone) 1 subcomplex unknown 1 [EC:1.6.99.3 1.6.5.3]
K03968  
NADH dehydrogenase (ubiquinone) 1 subcomplex unknown 2 [EC:1.6.99.3 1.6.5.3]
K00234  
succinate dehydrogenase (ubiquinone) flavoprotein subunit [EC:1.3.5.1]
K00235  
succinate dehydrogenase (ubiquinone) iron-sulfur subunit [EC:1.3.5.1]
K00236  
succinate dehydrogenase (ubiquinone) cytochrome b560 subunit
K00237  
succinate dehydrogenase (ubiquinone) membrane anchor subunit
K00411  
ubiquinol-cytochrome c reductase iron-sulfur subunit [EC:1.10.2.2]
K00412  
ubiquinol-cytochrome c reductase cytochrome b subunit
K00413  
ubiquinol-cytochrome c reductase cytochrome c1 subunit
K00414  
ubiquinol-cytochrome c reductase core subunit 1
K00415  
ubiquinol-cytochrome c reductase core subunit 2
K00416  
ubiquinol-cytochrome c reductase subunit 6
K00417  
ubiquinol-cytochrome c reductase subunit 7
K00418  
ubiquinol-cytochrome c reductase subunit 8
K00419  
ubiquinol-cytochrome c reductase subunit 9
K00420  
ubiquinol-cytochrome c reductase subunit 10
K02262  
cytochrome c oxidase subunit 3
K02256  
cytochrome c oxidase subunit 1 [EC:1.9.3.1]
K02261  
cytochrome c oxidase subunit 2
K02263  
cytochrome c oxidase subunit 4
K02264  
cytochrome c oxidase subunit 5a
K02265  
cytochrome c oxidase subunit 5b
K02266  
cytochrome c oxidase subunit 6a
K02267  
cytochrome c oxidase subunit 6b
K02268  
cytochrome c oxidase subunit 6c
K02270  
cytochrome c oxidase subunit 7a
K02271  
cytochrome c oxidase subunit 7b
K02272  
cytochrome c oxidase subunit 7c
K02273  
cytochrome c oxidase subunit 8
K02132  
F-type H+-transporting ATPase subunit alpha [EC:3.6.3.14]
K02133  
F-type H+-transporting ATPase subunit beta [EC:3.6.3.14]
K02136  
F-type H+-transporting ATPase subunit gamma [EC:3.6.3.14]
K02134  
F-type H+-transporting ATPase subunit delta [EC:3.6.3.14]
K02135  
F-type H+-transporting ATPase subunit epsilon [EC:3.6.3.14]
K02126  
F-type H+-transporting ATPase subunit a [EC:3.6.3.14]
K02127  
F-type H+-transporting ATPase subunit b [EC:3.6.3.14]
K02128  
F-type H+-transporting ATPase subunit c [EC:3.6.3.14]
K02138  
F-type H+-transporting ATPase subunit d [EC:3.6.3.14]
K02137  
F-type H+-transporting ATPase oligomycin sensitivity conferral protein [EC:3.6.3.14]
K02131  
F-type H+-transporting ATPase subunit 6 [EC:3.6.3.14]
K02125  
F-type H+-transporting ATPase subunit 8 [EC:3.6.3.14]
K08844  
leucine-rich repeat kinase 2 [EC:2.7.11.1]
K05688  
PTEN induced putative kinase 1 [EC:2.7.11.1]
K05687  
protein DJ-1
K08669  
HtrA serine peptidase 2 [EC:3.4.21.108]
K05862  
voltage-dependent anion channel protein 1
K15040  
voltage-dependent anion channel protein 2
K15041  
voltage-dependent anion channel protein 3
K05863  
solute carrier family 25 (mitochondrial adenine nucleotide translocator), member 4/5/6/31
K09565  
peptidyl-prolyl isomerase F (cyclophilin D) [EC:5.2.1.8]
K08738  
cytochrome c
K02084  
apoptotic protease-activating factor
K04399  
caspase 9 [EC:3.4.22.62]
K02187  
caspase 3 [EC:3.4.22.56]
Compound
C00002  
ATP
C00008  
ADP
C00009  
Orthophosphate
C00013  
Diphosphate
C00020  
AMP
C00027  
Hydrogen peroxide
C00082  
L-Tyrosine
C00355  
3,4-Dihydroxy-L-phenylalanine
C00704  
O2.-
C03758  
Dopamine
C04599  
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
C07593  
Rotenone
C11310  
1-Methyl-4-phenylpyridinium
Reference
  Authors
Thomas B, Beal MF
  Title
Parkinson's disease.
  Journal
Hum Mol Genet 16 Spec No. 2:R183-94 (2007)
Reference
  Authors
Lim KL, Lim TM
  Title
Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
  Journal
IUBMB Life 55:315-22 (2003)
Reference
  Authors
Moore DJ, West AB, Dawson VL, Dawson TM
  Title
Molecular pathophysiology of Parkinson's disease.
  Journal
Annu Rev Neurosci 28:57-87 (2005)
Reference
  Authors
Abou-Sleiman PM, Muqit MM, Wood NW
  Title
Expanding insights of mitochondrial dysfunction in Parkinson's disease.
  Journal
Nat Rev Neurosci 7:207-19 (2006)
Reference
  Authors
Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H
  Title
Progress in the pathogenesis and genetics of Parkinson's disease.
  Journal
Philos Trans R Soc Lond B Biol Sci 363:2215-27 (2008)
Reference
  Authors
Gandhi S, Wood NW
  Title
Molecular pathogenesis of Parkinson's disease.
  Journal
Hum Mol Genet 14 Spec No. 2:2749-2755 (2005)
Reference
  Authors
Lotharius J, Brundin P
  Title
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
  Journal
Nat Rev Neurosci 3:932-42 (2002)
Reference
  Authors
Eriksen JL, Wszolek Z, Petrucelli L
  Title
Molecular pathogenesis of Parkinson disease.
  Journal
Arch Neurol 62:353-7 (2005)
Reference
  Authors
Sidhu A, Wersinger C, Vernier P
  Title
Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
  Journal
FASEB J 18:637-47 (2004)
Reference
  Authors
Sidhu A, Wersinger C, Moussa CE, Vernier P
  Title
The role of alpha-synuclein in both neuroprotection and neurodegeneration.
  Journal
Ann N Y Acad Sci 1035:250-70 (2004)
Reference
  Authors
Dauer W, Przedborski S
  Title
Parkinson's disease: mechanisms and models.
  Journal
Neuron 39:889-909 (2003)
Reference
  Authors
Feany MB
  Title
New genetic insights into Parkinson's disease.
  Journal
N Engl J Med 351:1937-40 (2004)
Reference
  Authors
Beal MF
  Title
Experimental models of Parkinson's disease.
  Journal
Nat Rev Neurosci 2:325-34 (2001)
Reference
  Authors
Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A
  Title
Parkinson's disease: from causes to mechanisms.
  Journal
C R Biol 328:131-42 (2005)
Reference
  Authors
Vila M, Ramonet D, Perier C
  Title
Mitochondrial alterations in Parkinson's disease: new clues.
  Journal
J Neurochem 107:317-28 (2008)
Reference
  Authors
Vila M, Przedborski S
  Title
Targeting programmed cell death in neurodegenerative diseases.
  Journal
Nat Rev Neurosci 4:365-75 (2003)

DBGET integrated database retrieval system